Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Chang, Ying-Jun  [Clear All Filters]
Journal Article
He, H., Xu, P., Zhang, X., Liao, M., Dong, Q., Cong, T., Tang, B., Yang, X., Ye, M., Chang, Y.-J., et al. (2020). Aging-induced IL27Ra Signaling Impairs Hematopoietic Stem Cells.Blood.
Zhao, X.-Y., Yu, X.-X., Xu, Z.-L., Cao, X.-H., Huo, M.-R., Zhao, X.-S., Chang, Y.-J., Wang, Y., Zhang, X.-H., Xu, L.-P., et al. (2019). Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.Blood Adv3, 4312-4325.
Chang, Y.-J., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., Yan, C.-H., et al. (2018). Effects of low-dose glucocorticoid prophylaxis on chronic GVHD and GVHD-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial.Biol Blood Marrow Transplant.
Guo, Z.-P., Wang, T., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, X.-J., and Chang, Y.-J. (2016). Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor.Transfus Apher Sci.
Zhao, X.-Y., Pei, X.-Y., Chang, Y.-J., Yu, X.-X., Xu, L.-P., Wang, Y., Zhang, X.-H., Liu, K.-Y., and Huang, X.-J. (2019). First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation.Clin Infect Dis.
Zeng, Q.-Z., Zhang, Y.-Y., Wu, Y.-J., Zhang, Z.-Y., Zhang, J.-N., Fu, H.-X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Mo, X.-D., et al. (2020). Frequency, risk factors and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Liu, J., Gao, H., Xu, L.-P., Mo, X.-D., Liu, R., Liang, S., Wu, N., Wang, M., Wang, Z., Chang, Y.-J., et al. (2020). Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2 T cells activities after hematopoietic transplantation for blood malignancies.J Immunother Cancer8.
Luo, X.-H., Chang, Y.-J., and Huang, X.-J. (2014). Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation.J Immunol Res2014, 631951.
Wang, X.-L., Han, W., Zhao, P., Liu, X., Wang, J.-Z., Wang, F.-R., Yan, C.-H., Zhang, Y.-Y., Mo, X.-D., Wang, Y., et al. (2019). Incidence, Risk Factors, Outcomes and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant.
Wang, Y.-T., Kong, Y., Song, Y., Han, W., Zhang, Y.-Y., Zhang, X.-H., Chang, Y.-J., Jiang, Z.-F., and Huang, X.-J. (2016). Increased type 1 immune response in the bone marrow immune microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Lv, M., Zhao, X.-S., Hu, Y., Chang, Y.-J., Zhao, X.-Y., Kong, Y., Zhang, X.-H., Xu, L.-P., Liu, K.-Y., and Huang, X.-J. (2014). Monocytic and Promyelocytic Myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.Am J Hematol.
Wang, Z.-L., Liu, Y., Zhou, Y.-L., Li, J.-L., Sun, Q.-Y., Wu, L.-X., Wen, L., Lai, Y.-Y., Liu, Y.-R., Chang, Y.-J., et al. (2020). Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma.Eur J Haematol.
Chen, Q., Zhao, X., Fu, H.-X., Chen, Y.-H., Zhang, Y.-Y., Wang, J.-Z., Wang, Y., Wang, F.-R., Mo, X.-D., Han, W., et al. (2020). Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.Bone Marrow Transplant.
Huo, M.-R., Xu, Y.-J., Zhai, S.-Z., Lv, M., Wang, Y., Cao, L.-Q., Xu, L.-P., Zhang, X.-H., Chen, H., Chen, Y.-H., et al. (2018). Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.Hum Immunol.
Wang, X.-Y., Fan, Q.-Z., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., et al. (2019). The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.Cytometry B Clin Cytom.
Tian, D.-M., Wang, Y., Zhang, X.-H., Liu, K.-Y., Huang, X.-J., and Chang, Y.-J. (2016). Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation.Plos One11, e0156777.
Chang, Y.-J., Xu, L.-P., Wang, Y., Zhang, X.-H., Chen, H., Chen, Y.-H., Wang, F.-R., Han, W., Sun, Y.-Q., Yan, C.-H., et al. (2020). Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody.Bone Marrow Transplant.